Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Celularity Inc. (CELU) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Celularity Inc. (CELU), most recent 12 months reported: revenue $18.67M, net loss $45.86M. Latest balance sheet on file: liquid cash $6.17M, total debt $14M, net cash -$7.83M. From SEC filings. Others in Pharmaceutical Preparations: PRELUDE THERAPEUTICS INC · CASI PHARMACEUTICALS, INC. · Sol-Gel Technologies Ltd. · SCYNEXIS, Inc. · CytomX Therapeutics, Inc. · uniQure N.V. · EVOFEM BIOSCIENCES, INC. · Zhengye Biotechnology Holding Limited

Stock screener

Watchlist